CD8A and colorectal carcinoma: Accordingly, future CRC studies should incorporate delivery-optimization strategies (e.g., carrier cells, promoter/miRNA retargeting) and report standardized immunologic endpoints (CD8+ infiltration, antigen-presentation scores, interferon signatures) to enable cross-study synthesis [124].